David Gobel

Direttore/Membro del Consiglio presso ORGANOVO HOLDINGS, INC.

Patrimonio netto: 19 372 $ in data 30/04/2024

71 anni

36 relazioni

Health Technology

Finance

Government

Posizioni attive di David Gobel

Società	Posizione	Inizio	Fine
ORGANOVO HOLDINGS, INC.	Direttore/Membro del Consiglio	15/09/2020	-
ORGANOVO HOLDINGS, INC.	Independent Dir/Board Member	15/09/2020	-
Oisin Biotechnologies, Inc. Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA.	Direttore/Membro del Consiglio	01/12/2014	-
	Independent Dir/Board Member	01/12/2014	-
Methuselah Capital Management LLC Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia.	Amministratore Delegato	01/01/2017	-
	Fondatore	01/01/2017	-
Leucadia Therapeutics, Inc. Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware.	Direttore/Membro del Consiglio	01/10/2015	-
Methuselah Foundation	Amministratore Delegato	01/09/2001	-
Methuselah Foundation	Fondatore	01/09/2001	-
Turn Biotechnologies, Inc. Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA.	Presidente	01/05/2020	-
	Direttore/Membro del Consiglio	01/07/2018	01/05/2020

Storia della carriera di David Gobel

Precedenti posizioni note di David Gobel

Società	Posizione	Inizio	Fine
Volumetric Biotechnologies, Inc.	Direttore/Membro del Consiglio	01/04/2018	01/01/2020
Transportation Security Administration	Corporate Officer/Principal	01/01/2009	01/03/2013

Statistiche

Distribuzione geografica

Stati Uniti

Posizioni

Director/Board Member	5
Independent Dir/Board Member	2
Chief Executive Officer	2

Settori

Health Technology	5
Finance	2
Government	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	1
ORGANOVO HOLDINGS, INC.	Health Technology

Aziende private	7
Oisin Biotechnologies, Inc. Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA.	Health Technology
Methuselah Capital Management LLC Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia.	Finance
Leucadia Therapeutics, Inc. Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware.	Health Technology
Methuselah Foundation
Turn Biotechnologies, Inc. Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA.	Health Technology
Volumetric Biotechnologies, Inc.
Transportation Security Administration	Government

Vedi le connessioni aziendali